CC2018: Sepsis Update 2018 (T)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Trauma.
Recent randomized trials have provided data regarding resuscitation techniques, selection of vasoactive medications, and adjuncts such as steroids in the setting of sepsis. These are cutting-edge findings not yet integrated into the Surviving Sepsis Guidelines. Experts will provide a practical approach to the management of a septic patient in 2018. Topics to be covered include: updates to surviving sepsis guidelines, vasopressors, fluids, steroids and adjuncts, and antibiotics.
- Surviving Sepsis - Is That All?
Vanessa P. Ho, MD, MPH, FACS, Cleveland, Ohio
- Source Control and Role of New Antibiotics for Multi-Drug Resistant Organisms (MDROs)
Tanya L. Zakrison, MD, FACS, FRSCS, MPH, Miami, FL
- When Is It Time to Stop the Antibiotics? Is Less More?
Rishi Rattan, MD, Miami, FL
- Sepsis Prediction and Outcomes
Haytham M.A. Kaafarani, MD, MPH, FACS, Boston, MA
- Panel Discussion
Heather Evans, MD
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact firstname.lastname@example.org.
- If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Vanessa P. Ho, MD, MPH, FACS, Cleveland, Ohio - No Disclosures
Tanya L. Zakrison, MD, FACS, FRSCS, MPH, Miami, FL - No Disclosures
Rishi Rattan, MD, Miami, FL - No Disclosures
Haytham M.A. Kaafarani, MD, MPH, FACS, Boston, MA - No Disclosures
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit